Episode 1873 • • 1:35:06 - 1:39:37
1873: Supercycle
Eli Lilly Rettatrutide, Obesity Drugs, and Joy Loss
Eli Lilly is developing Rettatrutide, a new obesity drug that targets three hormones and reportedly leads to a 28% weight loss, comparable to bariatric surgery. While medical professionals call it "game-changing," critics point to side effects like "joy loss," where patients lose interest in food, sex, and other pleasures. The drug is expected to be submitted for FDA approval by the end of the year.